ID   Ubigene MSTO-211H LDHA KO
AC   CVCL_E0ZC
SY   LDHA Knockout cell line (MSTO-211H)
DR   Ubigene; YKO-H910
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 6535; LDHA.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; 6514; LATS1 + HGNC; 9508; PSEN1; Name(s)=LATS1-PSEN1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6515; LATS2; Simple; p.Met785_Leu798del14 (c.2355_2396del42); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1430 ! MSTO-211H
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//